about
IGF-I in the clinics: Use in retinopathy of prematurityInsulin-like growth factor 1 has multisystem effects on foetal and preterm infant developmentInsufficient evidence for 'shaken baby syndrome' - a systematic review.Cohort study of growth patterns by gestational age in preterm infants developing morbidity.Parents' presence and parent-infant closeness in 11 neonatal intensive care units in six European countries vary between and within the countries.Authors' overarching reply to all the responses received to the systematic literature review on shaken baby syndrome.Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.White matter changes in extremely preterm infants, a population-based diffusion tensor imaging study.Spontaneous brain activity in the newborn brain during natural sleep--an fMRI study in infants born at full term.A Novel Magnetic Resonance Imaging Score Predicts Neurodevelopmental Outcome After Perinatal Asphyxia and Therapeutic Hypothermia.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Shaken baby syndrome and the risk of losing scientific scrutiny.Pouring out the dirty bathwater without throwing away either the baby or its parents: commentary to Saunders et al.Brain abnormalities in extremely low gestational age infants: a Swedish population based MRI study.Downstream mRNA Target Analysis in Neonatal Hypoxic-Ischaemic Encephalopathy Identifies Novel Marker of Severe Injury: a Proof of Concept Paper.Hypoxic ischemic encephalopathy in newborns linked to placental and umbilical cord abnormalities.Cranial ultrasound and MRI at term age in extremely preterm infants.Minimal enteral nutrition during neonatal hypothermia treatment for perinatal hypoxic-ischaemic encephalopathy is safe and feasible.Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants.The acoustic hood: a patient-independent device improving acoustic noise protection during neonatal magnetic resonance imaging.Role of EEG background activity, seizure burden and MRI in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischaemic encephalopathy in the era of therapeutic hypothermia.Diffusion tensor imaging on teenagers, born at term with moderate hypoxic-ischemic encephalopathy.Improved nutrition for extremely preterm infants - A population based observational study.Is accepting circular reasoning in shaken baby studies bad science or misconduct?The scientific evidence regarding retinal haemorrhages. Response to Hellgren et al. and Levin.A misunderstanding. Response to Dr Bilo et al.What are acceptable conclusions? Response to Dr. Ludvigsson.The shaken baby syndrome report was not the result of a conspiracy. Response to Dr. Narang et al.Conflicts of interest issues. Response to Lucas et al.A trial with N-carbamylglutamate may not detect all patients with NAGS deficiency and neonatal onset.Neonatal magnetic resonance imaging and outcome at age 30 months in extremely preterm infants.Bumetanide for neonatal seizures-back from the cotside.Easier to see the speck in your critical peers’ eyes than the log in your own? Response to Debelleet alPredictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disabilityPassive induction of hypothermia during transport of asphyxiated infants: a risk of excessive coolingHyperglycemia in Extremely Preterm Infants-Insulin Treatment, Mortality and Nutrient IntakesEarly energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infantsSwedish consensus reached on recording, interpretation and reporting of neonatal continuous simplified electroencephalography that is supported by amplitude-integrated trend analysis
P50
Q28070089-382719F3-EB1E-4B7C-8EB5-55CD36FFEB15Q28073109-F85B0CF1-1418-4E1B-B36D-D53846E8F16EQ36263123-FB048621-7E90-416F-A5F0-7D866CFFDBDEQ37454261-C80D184B-B11D-4B7C-A5BC-3CBA57B91779Q38943523-74D38662-6718-4A92-8785-549F54155C6FQ39258550-6F2A9D50-C10E-4973-81DE-75A2C2DED485Q41235157-80B5E73B-D00F-4798-8CA4-EF72BA897006Q43596293-E64D1032-6535-49CC-A7F5-F3574DDDA5DEQ46305358-31549CC4-3FD1-4A26-8777-872699FBC6F6Q47098065-08D382EB-E9E5-42D6-8F6A-6BEF86D89626Q47568034-098479D8-F254-4904-A03D-8C469413A4DFQ47711498-383DE1C6-7A80-4013-ACAA-80A097C8F9B9Q48148374-4C209885-FB25-4771-A89F-ADC24B0E0865Q48157211-EDD59746-0DFE-42F8-A22A-FE7ED0B9DD43Q48274310-1FCF5DDC-2B7A-4DBE-8B4A-72B8CF7D0BAFQ48311016-46648EB4-08D6-43D2-8704-67C3E48BCF9BQ48429128-9E28375B-ADFE-4FF7-861E-C708D330D3FFQ48473802-AB5A3BFD-8DF2-443A-BFC7-AC26E4AB81BDQ48526161-B91F47FD-4893-43AB-A78E-C7C9415D62B4Q48620721-B9B77D9E-2B4D-4550-86B9-9C9A33CE2DFEQ48644206-9F370E21-F503-4821-81E9-8002F162B457Q48712556-D4B0156F-C306-4360-A1B5-A4E1E341ACB9Q49819592-37675C16-C5E9-4480-BE85-D02AA07DF9F2Q50435117-B73C1694-FF04-49BE-8119-0B9EFD655FBBQ50436847-0F075688-ACDB-4F2B-A91A-7AF2497400DFQ50441800-FABA90E0-252B-471C-9DC4-822A62CEC1FDQ50442041-F81B62DB-1542-46F7-B804-D2E334247AFEQ50442045-473337BB-9F58-4192-9F3A-BE236685C2A5Q50442050-73C2466F-DB1B-4D6C-B0B4-011B93070D15Q50775841-B384FFFC-C997-4F3B-8CEA-ADB63C020D97Q51848398-CC4DF686-CC3D-45DE-8FBC-038FDF772CB4Q52147245-31F7A926-D8C7-4314-849D-FEE0CED1D916Q60729926-F5D29E83-7E4A-4AA7-9BF4-0AFBADE83142Q73182494-358BEC08-A207-49FB-A83E-D28986DA064DQ83959789-E6B6FDBF-2E72-4D7B-9452-8C9F4123B72CQ88582738-EA4A5A32-69AE-4737-97F8-F447506EA1BBQ89050593-1B8F997D-F784-40CE-BCD7-7F383107F6E7Q89087205-5C2BC092-F50E-429E-AA8E-690B83D8629C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Boubou Hallberg
@ast
Boubou Hallberg
@en
Boubou Hallberg
@es
Boubou Hallberg
@nl
type
label
Boubou Hallberg
@ast
Boubou Hallberg
@en
Boubou Hallberg
@es
Boubou Hallberg
@nl
prefLabel
Boubou Hallberg
@ast
Boubou Hallberg
@en
Boubou Hallberg
@es
Boubou Hallberg
@nl
P214
P906
P106
P214
P31
P496
0000-0002-2928-3126
P569
1967-01-01T00:00:00Z
P7859
viaf-121542729